WHO declares first 21st century flu pandemic
Posted by daisymaxwell on June 11, 2009
Thu Jun 11, 2009
GENEVA (Reuters) – The World Health Organization declared the first flu pandemic of the 21st century on Thursday, urging countries to shore up defenses against the virus which is “not stoppable” but has proved mainly mild so far.
The United Nations agency raised its pandemic flu alert to phase 6 on a six-point scale, indicating the first influenza pandemic since 1968 is under way.
“No previous pandemic has been detected so early or watched so closely, in real time, right at the very beginning,” WHO Director-General Dr Margaret Chan said. “The world can now reap the benefits of investments, over the last five years, in pandemic preparedness.”
Acting on the recommendation of flu experts, the WHO reiterated its advice to its 193 member countries not to close borders or impose travel restrictions to halt the movement of people, goods and services, a call echoed by U.N. Secretary-General Ban Ki-moon.
The move to phase 6 reflects the fact that the disease, widely known as swine flu, was spreading geographically, but does not indicate how virulent it is.
Widespread transmission of the virus in Victoria, Australia, signaling that it is entrenched in another region besides North America, was one of the key triggers for moving to phase 6.
NO SURPRISE
“This is not a surprise,” Dr Thomas Frieden, new director of the U.S. Centers for Disease Control and Prevention, told a news conference. “It is expected based on the data.”
A unanimous experts’ decision was based on an overall assessment in the eight most heavily hit countries — Australia, Britain, Canada, Chile, Japan, Mexico, Spain and the United States — that the virus is spreading in a sustained way in communities, according to Chan.
“Collectively, looking at that, we are satisfied that this virus is spreading to a number of countries and it is not stoppable,” she said.
“Moving to pandemic phase six level does not imply we will see an increase in the number of deaths or very severe cases.
“Quite on the contrary. Many people are having mild disease, they recover without medicines in some cases and it is good news,” she said.
And measuring the impact of the disease as it develops and spreads is difficult.
“It is very hard to get a sense of how many people are really dying from something like pandemic flu,” acting Assistant Director-General Keiji Fukuda, the WHO’s top flu expert, said.
Chan said the WHO global assessment of the pandemic was that it was moderate, but at the national level the picture could be different.
“Although the pandemic appears to have moderate severity in comparatively well-off countries, it is prudent to anticipate a bleaker picture as the virus spreads to areas with limited resources, poor health care, and a high prevalence of underlying medical problems,” she said.
VACCINE PRODUCTION
The WHO recommended drugmakers stay on track to complete production of seasonal influenza vaccine for the northern hemisphere’s next winter in the next two weeks. Each year, normal flu kills up to 500,000 people and infects millions.
Seasonal flu affects mainly the elderly, and causes severe illness in millions, so a premature switch in vaccine production to cope with the new strain could put many people at risk.
“So our recommendation is they need to finish the seasonal vaccine and then move over. That is pretty good in terms of dove-tailing the production of the two types of vaccine. So I think that this may just work out,” Chan said.
Chan said the Geneva-based agency would work with regulatory authorities to help fast-track approval of new pandemic vaccines that are safe and effective so that they can be made available as soon as possible. In any case, the first doses would only be available in September, she added.
A pandemic could cause enormous disruption to business as workers stay home because they are sick or to look after family members and authorities restrict gatherings of large numbers of people or movement of people or goods.
World markets shrugged off the possibility of a pandemic, as investors focused on possible global economic recovery.
“But the tendency to move into complacency is our biggest concern. Because we need to continue to monitor this virus, follow its tracks and do not allow it to come back in the second wave to give us more trouble.
The new strain can be treated by antiviral drugs oseltamivir, the generic name of Roche Holding’s Tamiflu tablets, and Relenza, a spray made by GlaxoSmithKline.
The strain, which emerged in April in Mexico and the United States, has spread widely. There have been 28,774 infections reported in 74 countries to date, including 144 deaths, according to WHO’s latest tally of laboratory-confirmed cases.
But the real number of people with the disease is likely to run into at least hundreds of thousands, as mild cases may not have been detected.
